International Clinical Trial: Exploration of Efficacy Prediction and Mechanisms of Loss of Response to Infliximab in Crohn's Disease

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122035) titled 'Exploration of Efficacy Prediction and Mechanisms of Loss of Response to Infliximab in Crohn's Disease' on April 8.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The Second Affiliated Hospital of Zhengzhou University

Condition: Crohn's Disease

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-15

Target Sample Size: Observation Group of the Effect of Infliximab in Treating Crohn's Disease:200;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=316213

Published by HT Digital Content Services with...